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Abstract
Diabetes mellitus is a growing problem in South Africa and of concern to traditional African health
practitioners in the Nelson Mandela Metropole, because they experience a high incidence of diabetic cases in their
practices. A collaborative research project with these practitioners focused on the screening of Bulbine frutescens,
Ornithogalum longibracteatum, Ruta graveolens, Tarchonanthus camphoratus and Tulbaghia violacea for antidiabetic
and cytotoxic potential. In vitro glucose utilisation assays with Chang liver cells and C2C12 muscle cells, and growth
inhibition assays with Chang liver cells were conducted. The aqueous extracts of Bulbine frutescens (143.5%),
Ornithogalum longibracteatum (131.9%) and Tarchonanthus camphoratus (131.5%) showed significant increased
glucose utilisation activity in Chang liver cells. The ethanol extracts of Ruta graveolens (136.9%) and Tulbaghia
violacea (140.5%) produced the highest increase in glucose utilisation in C2C12 muscle cells. The ethanol extract of
Bulbine frutescens produced the most pronounced growth inhibition (33.3%) on Chang liver cells. These findings
highlight the potential for the use of traditional remedies in the future for the management of diabetes and it is
recommended that combinations of these plants be tested in future.
Keywords: Diabetes mellitus; Cytotoxicity; Collaborative research; Chang liver cells; C2C12 muscle cells.
Introduction
South African epidemiological data on diabetes mellitus show an increased incidence of diabetes in urban
areas as compared to rural areas and interestingly report a strong genetic component for the development of
diabetes in Xhosa-speaking people in the Eastern Cape (Molleutze and Levitt, 2005). The focus of this article is on
the potential of medicinal plants used by traditional health practitioners in the Nelson Mandela Metropole to influence
glucose utilisation in cells. These experiments were done in an interactive research setting which included
collaborating practitioners in the investigative process (van Huyssteen et al., 2004).
Medicinal plants were selected for the study according to their favourable sustainable cultivation profiles
established through a jointly developed medicinal garden and included Bulbine frutescens (L.) Wild.
(Asphodelaceae), Ornithogalum longibracteatum Jacq. (Ornithogaloideae: Hyacinthaceae), Ruta graveolens L.
(Rutaceae), Tarchonanthus camphoratus L. (Asteraceae) and Tulbaghia violacea Harv. (Alliaceae). In addition,
ethnobotanical data on R. graveolens reported its use in the management of diabetes mellitus in the Bredasdorp/Elim
area, Southern Cape, South Africa (Thring and Weitz, 2006). Furthermore, Allium sativum L. has been used for
diabetes in traditional Indian medicine (Mukherjee et al., 2006), which might indicate some potential for T. violacea
because the plants belong to the same family and possess a number of similar active ingredients (Cox and Ballick,
1994; Motsei et al., 2003). Interestingly, practitioners told us that they used T. camphoratus in remedies for diabetes
and this was also documented among communities living in the George/Knysna area (Southern Cape, South Africa)
by Yvette van Wijk (personal communication). Water and ethanol were used as extraction solvents because
collaborating practitioners used water as vehicle for most of their remedies, which was supported by numerous
literature citings (Eloff 1998; Grierson and Afolayan, 1999; Inngjerdingen et al., 2004; Kelmanson et al., 2004; Shale
et al., 1999). The second extraction solvent was ethanol, because it is relatively inexpensive and freely available to
practitioners (Louw et al., 2002).
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The objectives of the study were to test aqueous and ethanol extracts of these plants for in vitro glucose utilisation
activity into C2C12 muscle and Chang liver cells and cytotoxic activity in Chang liver cells. The focus point of which
was to share the results with participating practitioners in order to develop and promote transparent research within
the collaboration boundaries.
Methodology
Plant material collection and extraction procedures
All the plants were collected from the Nelson Mandela Metropolitan NMM area. Plant material was collected in
the early morning, kept in closed plastic bags and extracted fresh as soon as possible after harvesting (< 2 hours
after collection). Freshly harvested plant material was macerated in either deionised water or 99% ethanol at room
temperature in just enough solvent to cover it. The solvent was replaced every 24 hrs for three days. Extracts were
then vacuum-filtered through Whatman No1 filters. Ethanol extracts were concentrated in a rotary evaporator at a
temperature of ≤ 67ºC for a maximum of three hours.  Concentrated ethanol extracts that were not yet dry after three 
hours and aqueous extracts were freeze-dried. Dried extracts were stored in 50 ml polypropylene tubes in the dark at
4ºC in a desiccator. Table 1 summarises the plant parts used, month of collection, yield of dried extract in the case of
aqueous extracts and authentication of the plant. In the case of ethanol extracts, yields were not calculated, because
the dried extracts stuck to the round bottom flasks in which they were evaporated and could not be removed in an
accurate fashion. For this reason only the starting weights of the plant material were recorded for the ethanol
extracts (Table 1).
Table 1: Plant material extraction data.
Name Plant part Month of
collection
Aqueous yield (w/w)
(Ethanol starting
weight)
Authentication
Bulbine frutescens Whole January 2.05%
(51.92g)
None
Ornithogalum
longibracteatum
Bulb June 1.14%
(646.95g)
Dr D du Preez
Dept of Botany
NMMU
Ruta graveolens Arial parts December 12.67%
(36.03g)
None
Tarchonanthus
camphoratus
Leaves
/soft twigs
October 6.45%
(23.06g)
Identified tree on campus
Tulbaghia violacea Whole October 2.31%
(40.93g)
Prof E Campbell
Dept of Botany
NMMU
Routine maintenance of cell cultures
Chang liver cells and C2C12 muscle cells were maintained in 10 cm culture dishes and incubated at 37ºC in
a 5% CO2 environment. Growth medium consisted of RPMI-1640 (BioWhittaker, Walkerville, USA) supplemented
with 10% fetal bovine serum (fbs; Delta Bioproducts, Johannesburg, South Africa). Growth medium was changed
every 48 to 72 hrs. When about 70% confluence was reached, cells were detached by washing with phosphate-
buffered saline-A (PBSA) and incubating with trypsin 0.25% (v/v) in PBSA (Roche Diagnostics, Manheim, Germany).
Cells were routinely divided at a split ratio of one in six.
Glucose utilisation in C2C12 muscle cells
C2C12 muscle cells were seeded into flat-bottom 96-well culture plates (NUNC, Roskilde, Denmark) at a
density of 5 000 cells/well in a volume of 200 µl/well growth medium. The plates were incubated for three and a half
days at 37ºC without changing the medium. On the day of the assay all reagents were made up with incubation
buffer (RPMI-1640 with an adjusted glucose concentration of 8 mM using phosphate-buffered saline (PBS) plus 0.1%
(m/v) BSA). The spent growth medium was aspirated and 50 µl of incubation buffer with or without insulin (1 µM;
Human, recombinant; Roche, Penzberg, Germany) or test samples (0.5 and 50 µg/ml) were added to each well. The
plates were incubated for one hour at 37ºC. After incubation, 10 µl aliquots were taken from each well and
transferred to an empty 96-well microtiter plate. Two hundred microliters of the glucose oxidase reagent (Sera-pak
Plus, Hong Kong) was added to each 10 µl aliquot and developed for 15 minutes at 37ºC. The plate was read after
development at 492 nm in a multiplate reader (Multiscan MS® version 4.0 Labsystem® type 352).
Van Huyssteen et al., Afr J Tradit Complement Altern Med. (2011) 8(2):150-158 152
Glucose standards were run with each experiment. The standards were made up with the incubation buffer
(containing 0.1% (m/v) BSA) at concentrations of 2, 4, 6 and 7 mM diluted with PBS. PBS was also used as the
blank. The glucose concentration (± 8 mM) in the incubation buffer given to the cells at zero time, was also
determined with the same method. Results were expressed as percentage glucose uptake as compared to control
cells of which the glucose uptake was assigned as 100%.
% GU = (Avg: T0 – TS) x 100%
[Avg: (Avg T0 – NC)]
Key: Avg = average; GU = glucose uptake or utilisation; NC = negative control measurement;
T0 = zero time measurement; TS = test sample measurement
Data was recalculated in some cases to allow for the variation in insulin response between experiments. These
variations were attributed to slight variations in seeding densities, time of cell growth and differentiation of the cells.
In these cases, the data were expressed as a percentage of the insulin response (0%):
% GU as a function of IR = % GU of TS – Avg: (%GU of insulin) x 100%
Avg: (% GU of Insulin)
Key: Avg = average; GU = glucose uptake or utilisation; IR = insulin response
Glucose utilisation assay in Chang liver cells
Chang liver cells were seeded into flat-bottom 96-well culture plates (NUNC, Roskilde, Denmark) at a
density of 6 000 cells/well in a volume of 200 µl/well growth medium. After about 72 hours, 10 µl of fresh growth
medium, containing either no additive, metformin (1 µM; Helm AG, Hamburg, Germany) or test sample (0.125 or 12.5
µg/ml), was added to the 200 µl medium already in the well (ethanol extracts contained a maximum of 1.25% (v/v)
DMSO, which was used for the initial dissolution of these extracts). The final metformin concentration in the medium
was 1 µM and the extract concentrations were 0.125 and 12.5 µg/ml. The cells were exposed to these extracts or
metformin for 48 hours before the glucose utilisation assay was done.
On the day of the glucose utilisation assay, incubation buffer (RPMI-1640 diluted with phosphate-buffered
saline (PBS) to 8 mM glucose with 0.1% (m/v) bovine serum albumin (BSA; Roche Diagnostics, Germany)) was
prepared with and without metformin (1 µM) or test sample (0.5 or 50 µg/ml). The spent growth medium was
aspirated from the wells and 50 µl of each solution were added per well. The cells were incubated at 37ºC for a
further 3 hours for glucose utilisation to occur.
After three hours of incubation at 37ºC, glucose utilisation was determined as in section 2.3. Concurrently
with the glucose assay, a viability assay utilising MTT (Sigma, Germany) was also done in separate wells to detect
any possible liver cell toxicity of the test samples during the 48 hr exposure period (Mosmann, 1983). One-hundred
microliters of 0.5 mg/ml MTT in growth medium was added per well and incubated at 37ºC for 3 hours. At the end of
the incubation time, this solution was aspirated and 100 µl DMSO added to each well to dissolve the formazan
crystals formed in the cells. The plate was shaken for 60 seconds to dissolve the formazan salts and read at 540 nm
with a multiplate reader (Multiscan MS® version 4.0 Labsystem® type 352).
Results were expressed as percentage glucose uptake as compared to control cells of which the glucose uptake was
assigned as 100%. Results from the MTT viability assay were taken into account to normalise the data (i.e. to
compensate for differences in cell numbers with different extracts).
% GU = (Avg: T0 – TS492nm) x 100% x (TS540nm)
[ Avg: (Avg: T0)-NC492nm] (Avg: NC540nm)
Key: Avg = average; NC = negative control; T0 = zero time; TS = test sample
Cytotoxicity assay on Chang liver cells
Chang liver cells were seeded into flat-bottom 96-well culture plates (NUNC, Roskilde, Denmark) at a
density of 6 000 cells/well in a volume of 200 µl/well growth medium. The next morning, the medium was replaced
with 200 µl fresh growth medium or growth medium containing different concentrations of crude extracts (125 and
62.5 µg/ml). Additionally, ethanol extracts contained 0.31 and 0.63% (v/v) DMSO (Associated Chemical Enterprises,
South Africa) to dissolve the extracts and corresponding negative controls also contained these amounts of DMSO.
The cells were exposed to the various buffers for 48 hrs at 37ºC after which the MTT assay was performed as
described above.
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Results are expressed as percentage growth inhibition, taking the growth of the corresponding negative control to be
100%.
% GI = (Avg: NC – T) x 100%
Avg: NC
Key: Avg = average; GI = growth inhibition; NC = negative control readings; T = sample readings
Statistical analysis
Results were statistically analysed using GraphPad Prism® 4 (Graphpad Software, 2003). Means and
standard error of the mean (SEM) values were calculated and used in statistical tests to determine significance. The
unpaired t-test was used to compare the negative control values with sample values. Results were considered
statistically significant if p < 0.05. Glucose utilisation responses were further compared to the response of the relative
positive control to ascertain if the response produced by the extract were significant or not.
Results
Table 2 provides a summary of the average percentage glucose uptake achieved in C2C12 muscle cells by
aqueous and ethanol extracts (0.5 and 50 µg/ml). Aqueous extracts that increased glucose utilisation more than
insulin included both concentrations of Bulbine frutescens (130.1%; 121.3%) and the 0.5 µg/ml concentration of
Ornithogalum longibracteatum (129.2%), Ruta graveolens (124.7%) and Tarchonanthus camphoratus (128.4%).
Significant concentration-independent responses were observed for B. frutescens (p < 0.05), O. longibracteatum (p <
0.005) and T. camphoratus (p <0.05). The largest increase in glucose utilisation for ethanol extracts was produced
by Tulbaghia violacea (0.5 µg/ml; 140.5%), which showed a significant concentration-independent response (p <
0.05). The two extracts of O. longibracteatum were the only ethanol extracts that produced a concentration-
dependent increase in glucose utilisation (p < 0.05).
Table 2: Percentage glucose taken up (± SEM) by C2C12 muscle cells. Cells were treated for one hour with
aqueous and ethanol extracts (0.5 or 50 µg/ml) of Bulbine frutescens, Ornithogalum longibracteatum, Ruta
graveolens, Tarchonanthus camphoratus and Tulbaghia violacea at 37ºC.
Plant Concen-
tration
(µg/ml)
Aqueous extracts
% glucose uptake ± SEM Ethanol extracts
% glucose uptake ± SEM
Negative control 0 100 ± 1.53 100 ± 2.78
Insulin 1 µM 119.7 ± 1.46 *** 117.9 ± 2.53***
0.5 130.1 ± 2.43 *** 128.3 ± 6.65***B. frutescens
50 121.3 ± 3.05 *** 123.4 ± 3.41***
0.5 129.2 ± 4.19 *** 118.3 ± 5.26**O. longibracteatum
50 113.9 ± 2.72 *** 133.0 ± 4.74***
0.5 124.7 ± 3.30 *** 136.9 ± 10.85***R. graveolens
50 118.1 ± 1.68 *** 124.1 ± 3.74***
0.5 128.4 ± 3.27*** 131.6 ± 6.54***T. camphoratus
50 117.4 ± 2.75*** 129.7 ± 4.31***
0.5 119.0 ± 2.57*** 140.5 ± 5.56***T. violacea
50 116.8 ± 2.203*** 117.7 ± 6.66**
Averages and p-values were calculated with the two-tailed unpaired t-test from three to six experiments per sample
and with 12 replicates per sample for each experiment (* p < 0.05; ** p < 0.005; *** p < 0.0005).
Extracts were also tested in combination with insulin to see whether the combination was more effective in
increasing glucose utilisation in C2C12 muscle cells than when used alone. All glucose utilisation values were
recalculated to obtain the percentage response compared to an insulin response of 0%. The 50 µg/ml aqueous
extracts of R. graveolens (p < 0.05) and T. camphoratus (p < 0.005) produced statistically significant increased
combined responses as compared to the extracts alone (Figure 1). Additionally, the glucose utilisation activity of the
50 µg/ml concentration of the ethanol extracts of B. frutescens (p < 0.05), R. graveolens (p < 0.05), T. camphoratus
(p < 0.05) and T. violacea (p < 0.005) were significantly potentiated when they were combined with insulin, which may
point to an additive or synergistic effect with insulin (Figure 2). However, glucose utilisation activity significantly
decreased when insulin was added to the 0.5 µg/ml ethanol extracts of T. camphoratus (p < 0.05) and T. violacea
(p < 0.0005) in comparison to the response with these extracts alone.
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Figure 1: Percentage glucose uptake (± SEM) produced on C2C12 muscle cells by aqueous extracts with and
without insulin as compared to the insulin response (taken as 0%). Cells were treated for 1 hour with aqueous
extracts (0.5 or 50 µg/ml) of Bulbine frutescens (Bf), Ornithogalum longibracteatum (Ol), Ruta graveolens (Rg),
Tarchonanthus camphoratus (Tc) and Tulbaghia violacea (Tv) and these aqueous extracts combined with
insulin (1 µM, represented with a +) at 37ºC. Normal bars represent 10 experiments with 12 replicates per
sample for the extract alone and checked bars represent seven individual experiments with the same amount of
replicates per sample. The zero gridline indicates percentage glucose uptake of insulin (1 µM). Statistical
significant changes in response of the extract with and without insulin are indicated with appropriately pointed
arrows and stars above the corresponding arrow indicate the degree of significance (p < 0.05* and p < 0.005**).
Table 3 provides a summary of the average percentage glucose uptake achieved in Chang liver cells by
aqueous and ethanol extracts tested at 0.5 and 50 µg/ml. The glucose uptake values were normalised according to
cell viability variations (determined by the MTT assay) that might have occurred during the 48 hour exposure period
to the different extracts. Aqueous extracts that significantly increased glucose uptake into Chang liver cells were B.
frutescens (0.5 µg/ml; 143.5%), O. longibracteatum (0.5 µg/ml; 131.9%), T. camphoratus (50 µg/ml; 131.5%) and
T. violacea (50 µg/ml; 124.5%). Significant concentration-independent responses were recorded for the aqueous
extracts of B. frutescens (p < 0.0001) and O. longibracteatum (p < 0.0005) and significant concentration-dependent
responses for the aqueous extracts of T. camphoratus (p < 0.05) and T. violacea (p < 0.005). The ethanol extract of
T. camphoratus (0.5 µg/ml; 126.9%) produced the greatest glucose utilisation response of the ethanol extracts on
Chang liver cells. In summary, the aqueous extracts produced better glucose uptake into Chang liver cells than the
ethanol extracts. Interestingly, the aqueous extracts of B. frutescens (0.125 µg/ml) and T. violacea (12.5 µg/ml) were
the only to produce significant growth inhibition, although very mild.
Cytotoxicity testing of increased concentrations (62.5 and 125 µg/ml) of the extracts on Chang liver cells are
summarised in Table 4. In this case, ethanol extracts were more cytotoxic than aqueous extracts. The ethanol
extract of B. frutescens (62.5 µg/ml) produced the largest growth inhibition (33.3%), followed by T. camphoratus (125
µg/ml; 28.05%) and T. violacea (125 µg/ml; 23.3%). The only aqueous extract that produced significant growth
inhibition on Chang liver cells was O. longibracteatum (62.5 µg/ml; 18.1%).
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Figure 2: Percentage glucose uptake (± SEM) produced on C2C12 muscle cells by ethanol extracts with and without
1 µM insulin as compared to the insulin response (taken as 0%). Cells were treated for 1 hour with ethanol
extracts (0.5 and 50 µg/ml) of Bulbine frutescens (Bf), Ornithogalum longibracteatum (Ol), Ruta graveolens
(Rg), Tarchonanthus camphoratus (Tc) and Tulbaghia violacea (Tv) and these extracts combined with insulin
(represented with a +) at 37ºC. Normal bars represent two experiments with 12 replicates per sample for the
extract alone and checked bars represent two individual experiments per extract with the same amount of
replicates per sample. The zero gridline indicates percentage glucose uptake of insulin (1 µM). Statistical
significant changes in response of the extract with and without insulin are indicated with appropriately pointed
arrows and stars above the corresponding arrow indicate the degree of significance (p < 0.05*, p < 0.005** and
p < 0.0005***).
Table 3: Percentage glucose uptake (± SEM) by Chang liver cells. Cells were treated for 48 hours (0.125 or 12.5
µg/ml) and again for three hours (0.5 or 50 µg/ml) with aqueous extracts and ethanol extracts of Bulbine
frutescens, Ornithogalum longibracteatum, Ruta graveolens, Tarchonanthus camphoratus and Tulbaghia
violacea at 37ºC.
Plant Concen-
tration
(µg/ml)
Aqueous extracts
% glucose uptake ± SEM
Ethanol extracts
%glucose uptake ± SEM
Negative control 0 100 ± 1.98 100 ± 1.71
Metformin 1 µM 115.4 ± 2.23*** 110.1 ± 1.83***
0.5 143.5 ± 5.69*** 110.8 ± 2.60**B. frutescens
50 111.4 ± 2.40* 104.1 ± 6.17
0.5 131.9 ± 4.25*** 106.7 ± 4.41O. longibracteatum
50 109.5 ± 2.26* 110.7 ± 2.08**
0.5 114.2 ± 5.37** 101.3 ± 2.05R. graveolens
50 114.7 ± 3.45** 117.7 ± 3.07***
0.5 116.7 ± 5.83** 126.9 ± 3.84***T. camphoratus
50 131.5 ± 4.20*** 101.4 ± 3.87
0.5 98.44 ± 3.46 100.1 ± 3.69T. violacea
50 124.5 ± 7.01*** 100.6 ± 5.73
Averages and p-values were calculated with the two-tailed unpaired t-test from two to three experiments with 10
replicates per sample per experiment (* p < 0.05; ** p < 0.005; *** p < 0.0005)
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Table 4: Percentage growth inhibition (± SEM) produced on Chang liver cells. Cells were exposed to aqueous or
ethanol extracts (62.5 and 125 µg/ml) of Bulbine frutescens, Ornithogalum longibracteatum, Ruta graveolens,
Tarchonanthus camphoratus and Tulbaghia violacea for 48 hrs at 37ºC.
Sample Concentration
(µg/ml)
Aqueous extracts
% inhibition ± SEM
Ethanol extracts
% inhibition ± SEM
Negative control 0 0.51 ± 2.78 -0.18 ± 3.50
62.5 -9.67 ± 6. 44 33.31 ± 5.94***B. frutescens
125 -18.15 ± 5.10** 30.06 ± 3.72***
62.5 18.14 ± 4.14** -23.66 ± 9.09*O. longibracteatum
125 17.53 ± 5.80* -15.30 ± 5.29*
62.5 -22.96 ± 7.30** -7.51 ± 7.63R. graveolens
125 -18.71 ± 7.18** 1.65 ± 6.24
62.5 -3.55 ± 4.51 -9.31 ± 3.69T. camphoratus
125 5.56 ± 4.11 28.05 ± 3.94***
62.5 4.65 ± 2.99 19.38 ± 5.19**T. violacea
125 6.63 ± 3.13 23.27 ± 4.76 ***
Averages and p-values were calculated from two to four independent experiments for each sample, with eight
replicates per sample per experiment. P-values were calculated using the two-tailed unpaired t-test (* p < 0.05; ** p <
0.005; *** p < 0.0005).
Discussion
These scientific findings were communicated to participating traditional health practitioners through feedback
seminars. The feedback seminars were based on interactive workshops which were initially used in the collaboration
to exchange information regarding disease conditions (van Huyssteen et al., 2004). The seminars described
methodology employed in the screenings and subsequent findings as accurately as possible with the assistance of
interpreters, demonstrations, photos and translated notes. The interactive nature of the seminars encouraged two-
way discussions and practitioners shared that they used Bulbine frutescens and Ornithogalum longibracteatum in
their diabetic remedies.
B. frutescens and O. longibracteatum produced similar glucose utilisation profiles; with B. frutescens
producing slightly more potent glucose utilisation activity than O. longibracteatum. The extracts of B. frutescens
increased glucose utilisation (except for the ethanol extracts in Chang liver cells) in both cell lines in a concentration-
independent manner. Similar dose-independent responses have been observed for knipholone, one of the active
ingredients contained in B. frutescens, in a leukotriene biosynthesis assay (Wube et al., 2006). In addition, glucose
utilisation was significantly enhanced for the 50 µg/ml ethanol extract when combined with insulin as compared to the
response of the extract alone. However, the ethanol extract of B. frutescens was found to have toxic effects on the
growth of Chang liver cells at concentrations of 62.5 and 125 µg/ml.
Apart form the glucose utilisation activity, the aqueous extract of O. longibracteatum produced significant,
but minor growth inhibitory effects on Chang liver cells (62.5 µg/ml; 18.14 ± 4.14%). Concern about the potential
toxicity of O. longibracteatum has been raised (Van Wyk et al., 2002) and toxicity evaluations have provided
unequivocal results (Mulholland et al., 2004). The bulb that was extracted for this study was approximately three
years old and had flowered during this time. The little toxicity produced in this study seems to support literary
observations which suggest that pre-flowering young plants as well as the fruits (Watt and Breyer-Brandwijk, 1962)
and leaves (Verschaeve et al., 2004) of the plant are more toxic.
The ethanol extract of Ruta graveolens produced a significant increase in glucose utilisation activity in
C2C12 muscle cells. This response might have been caused by the presence of the hypoglycaemic flavanoid,
quercetin (Mukherjee et al., 2006), in the R. graveolens extracts. In addition, the presence of insulin (1 µM)
significantly potentiated the glucose utilisation responses for both aqueous and ethanol extracts (50 µg/ml) by 4 and
14%, respectively as compared to the activity of the extracts alone. Interestingly, the antioxidant action of quercetin
(Wube et al., 2006) has been shown to increase insulin sensitivity in muscle cells (Laight et al., 2000). R. graveolens
produced no toxicity in any of the screens, except growth stimulation produced by the aqueous extract on Chang liver
cells. However, the continued use of R. graveolens has been disputed by many scientists due to potential toxicity
and serious side-effects induced by this plant (Van Wyk et al., 2002).
Tarchonanthus camphoratus contains many compounds that may be potentially hypoglycaemic, including
saponins (Mukherjee et al., 2006), flavanones and tannins (Scott and Springfield, 2005). It was thus interesting to
see that the aqueous extracts were more effective at increasing glucose utilisation in Chang liver cells and the
ethanol extracts in C2C12 muscle cells, both following concentration-independent trends. The glucose utilisation
responses in C2C12 muscle cells were significantly influenced by the presence of insulin and this phenomena
warrants further investigation. The cytotoxicity trend of the ethanol extracts in Chang liver cells suggests increased
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toxicity with increased concentrations. Participating practitioners also noted that they always used T. camphoratus in
combination with other plants to “stop the strongness”, despite the fact that they used water in most of their remedies.
However, literature reassures that the leaves of T. camphoratus are the subject of regular feeding by a variety of wild
and domestic animals (Venter and Venter, 2002; Watt and Breyer-Brandwijk, 1962) especially during summer (Parker
et al., 2003), which was when the leaves for this study were collected.
The green parts and flowers of Tulbaghia violacea had been consumed as vegetables (Marshalkar, 2003;
Roberts, 1990) and more recently, it showed an absence of genotoxicity in the Ames and VITOTOX® tests (Elgorashi
et al., 2003). However, cytotoxicity was observed at 62.5 and 125 µg/ml for the ethanol extract on Chang liver cells.
At the same time, T. violacea contains several ingredients such as steroidal saponins, quercetin, kaempherol, sugars,
and / or sulfur-containing compounds (Duncan et al., 1999) that might be considered glucose lowering. Similar sulfur-
containing compounds in garlic have been shown to be hypoglycaemic in diabetic animals and has been ascribed to
their anti-oxidant activity and the interaction of these compounds with thiol-containing proteins (Mukherjee et al.,
2006). Accordingly, the aqueous extract of T. violacea (50 µg/ml) showed significant increased glucose uptake
activity into Chang liver cells (124.5%) and the ethanol extract (0.5 and 50 µg/ml) into C2C12 muscle cells (140.5%
and 117.7%, respectively). Similar to the ethanol extracts of T. camphoratus, the presence of insulin influenced the
glucose utilisation response into muscle cells significantly as compared to the response of the extracts alone.
In returning to an ethnobotanical text, not all the plants in a diabetic remedy may necessarily have
antihyperglycaemic activity (Alarcon-Aguilara et al., 1998). Practitioners of this collaboration explained that additional
plants used in the remedies were either added to enhance the activity of the active plants or to stop toxic side-effects
of another plant. This is in accordance with literature, which states that cytotoxic concerns are often addressed by
indigenous cultures through using combinations of very small amounts of different plants in diabetic remedies
(Alarcon-Aguilara et al., 1998; Li et al., 2004; Tahraoui et al., 2007; Ziyyat et al., 1997). Accordingly, new trends in
ethnopharmacology suggest the investigation of synergy between plants in remedies (Gilani and Atta-ur-Rahman,
2005). Recent evidence on the pathology of diabetes suggests an increasing amount of targets that might prolong
the onset of type 2 diabetes mellitus (T2DM) ie. treating causes of insulin resistance, inflammation, the
procoagulative state, obesity etc. In light of this, natural products or crude extracts of natural products may exhibit
more than one mechanism which may potentially (Raghav et al., 2006) prolong the development, improve treatment
and/or prevent complications of T2DM. In conclusion, the favourable glucose utilisation profiles of most of the plants
tested in the study highlights the potential effectiveness of traditional remedies in the management for diabetes
mellitus. However, preliminary toxicity results reinforce the need to determine optimal and safe dosing
measurements if these remedies are to be used.
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